loading
Schlusskurs vom Vortag:
$8.25
Offen:
$8.28
24-Stunden-Volumen:
11,897
Relative Volume:
0.15
Marktkapitalisierung:
$43.40M
Einnahmen:
$7.97M
Nettoeinkommen (Verlust:
$-75.74M
KGV:
-0.3175
EPS:
-24.2853
Netto-Cashflow:
$-85.33M
1W Leistung:
-20.98%
1M Leistung:
-23.34%
6M Leistung:
+37.86%
1J Leistung:
-19.16%
1-Tages-Spanne:
Value
$7.70
$8.469
1-Wochen-Bereich:
Value
$7.86
$10.06
52-Wochen-Spanne:
Value
$3.76
$46.80

Aligos Therapeutics Inc Stock (ALGS) Company Profile

Name
Firmenname
Aligos Therapeutics Inc
Name
Telefon
(800) 466-6059
Name
Adresse
ONE CORPORATE DR., 2ND FLOOR, SOUTH SAN FRANCISCO
Name
Mitarbeiter
70
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-06
Name
Neueste SEC-Einreichungen
Name
ALGS's Discussions on Twitter

Vergleichen Sie ALGS mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
ALGS
Aligos Therapeutics Inc
8.11 57.35M 7.97M -75.74M -85.33M -24.29
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
421.15 109.11B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
633.80 68.50B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
435.50 60.25B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
818.98 50.39B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
181.29 40.44B 447.02M -1.18B -868.57M -6.1812

Aligos Therapeutics Inc Stock (ALGS) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-08-18 Fortgesetzt H.C. Wainwright Buy
2024-08-19 Eingeleitet H.C. Wainwright Buy
2023-01-06 Hochstufung Jefferies Hold → Buy
2023-01-06 Hochstufung Piper Sandler Neutral → Overweight
2022-03-23 Herabstufung Piper Sandler Overweight → Neutral
2022-01-07 Herabstufung JP Morgan Overweight → Neutral
2022-01-06 Herabstufung Jefferies Buy → Hold
2021-09-09 Eingeleitet SVB Leerink Outperform
2021-05-17 Fortgesetzt Piper Sandler Overweight
2020-11-10 Eingeleitet Cantor Fitzgerald Overweight
2020-11-10 Eingeleitet JP Morgan Overweight
2020-11-10 Eingeleitet Jefferies Buy
2020-11-10 Eingeleitet Piper Sandler Overweight
Alle ansehen

Aligos Therapeutics Inc Aktie (ALGS) Neueste Nachrichten

pulisher
07:32 AM

How to build a dashboard for Aligos Therapeutics Inc. stock2025 Market Outlook & Fast Exit and Entry Strategy Plans - newser.com

07:32 AM
pulisher
05:41 AM

Why Aligos Therapeutics Inc. stock remains on buy listsJuly 2025 Patterns & Weekly Top Stock Performers List - newser.com

05:41 AM
pulisher
04:18 AM

How buybacks impact Aligos Therapeutics Inc. stock valueMarket Growth Report & Weekly High Potential Stock Alerts - newser.com

04:18 AM
pulisher
04:03 AM

How to forecast Aligos Therapeutics Inc. trends using time series2025 Breakouts & Breakdowns & Community Shared Stock Ideas - newser.com

04:03 AM
pulisher
Nov 02, 2025

Is Aligos Therapeutics Inc a good long term investmentChart Pattern Recognition & Free Rapid Return Acceleration - earlytimes.in

Nov 02, 2025
pulisher
Nov 02, 2025

Is Aligos Therapeutics Inc. (5WK0) stock resilient in recession scenariosTrade Entry Report & AI Enhanced Market Trend Forecasts - newser.com

Nov 02, 2025
pulisher
Nov 01, 2025

Is Aligos Therapeutics Inc. stock positioned well for digital economy2025 Major Catalysts & Free Growth Oriented Trading Recommendations - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

How Aligos Therapeutics Inc. (5WK0) stock stacks up against competitors2025 Risk Factors & Growth-Oriented Investment Plans - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Multi factor analysis applied to Aligos Therapeutics Inc.Trade Analysis Report & Real-Time Volume Surge Alerts - newser.com

Nov 01, 2025
pulisher
Oct 31, 2025

Aligos Therapeutics, Inc. (ALGS) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK

Oct 31, 2025
pulisher
Oct 31, 2025

Is Aligos Therapeutics Inc. stock supported by strong fundamentalsEarnings Overview Report & Precise Buy Zone Tips - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Published on: 2025-10-31 04:14:04 - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Is Aligos Therapeutics Inc. (5WK0) stock a fit for income portfoliosDollar Strength & Weekly Stock Performance Updates - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Is Aligos Therapeutics Inc. (5WK0) stock safe for risk averse investors2025 Volume Leaders & Long-Term Growth Stock Strategies - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Can Aligos Therapeutics Inc. (5WK0) stock double in coming yearsTrade Entry Report & Safe Capital Growth Plans - newser.com

Oct 31, 2025
pulisher
Oct 30, 2025

Aligos Therapeutics to Announce 3rd Quarter 2025 Financial Results on November 6, 2025 - The Manila Times

Oct 30, 2025
pulisher
Oct 30, 2025

Aligos Therapeutics (Nasdaq: ALGS) to announce financial results Nov 6, 2025 - Stock Titan

Oct 30, 2025
pulisher
Oct 29, 2025

Aligos Therapeutics (ALGS) Expected to Announce Earnings on Wednesday - MarketBeat

Oct 29, 2025

Finanzdaten der Aligos Therapeutics Inc-Aktie (ALGS)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$37.24
price down icon 0.66%
$92.89
price down icon 0.72%
$28.82
price up icon 0.84%
$104.23
price up icon 0.19%
biotechnology ONC
$311.64
price up icon 0.32%
$181.29
price down icon 4.26%
Kapitalisierung:     |  Volumen (24h):